Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: Studies with fluoxetine and DOI

Molecular Brain Research

Volumn 54, Issue 1, 1998, Pages 64-73

  Mijnster, M Janneke ^a   Galis De Graaf, Yvonne ^a   Voorn, Pieter ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

5 Hydroxytryptamine; Basal ganglia; Dynorphin; Enkephalin; GABA; In situ hybridization; Substance P

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; BRAIN PROTEIN; DYNORPHIN; FLUOXETINE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; MESSENGER RNA; NEUROPEPTIDE; PREPRODYNORPHIN; PREPROENKEPHALIN; RITANSERIN; SEROTONIN 2 AGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; GLOBUS PALLIDUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

AMPHETAMINES; ANIMALS; CORPUS STRIATUM; FLUOXETINE; GLOBUS PALLIDUS; GLUTAMATE DECARBOXYLASE; INJECTIONS, INTRAPERITONEAL; MALE; NEUROPEPTIDES; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN; SEROTONIN AGONISTS;

ANIMALIA; EUKARYOTA;

EID: 0031933808     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00321-5     Document Type: Article

References (55)

1. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
2. 125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. J. Pharm. Exp. Ther. 255:1990;843-857.
3. Baldessarini R.J., Marsh E.R., Kula N.S. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res. 579:1992;152-156.
4. Benloucif S., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharm. Exp. Ther. 265:1993;373-377.
5. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders - an update. Trends Neurosci. 19:1996;417-422.
6. Chesselet M.F., Mercugliano M., Soghomonian J.J., Salin P., Qin Y., Gonzales C. Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. Prog. Brain Res. 99:1993;143-154.
7. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. 82:1985;4291-4295.
8. Clark R.N., Ashby C.R., Dewey S.L., Ramachandran P.V., Strecker R.E. Effect of acute and chronic fluoxetine treatment on extracellular dopamine levels in the caudate putamen and nucleus accumbens of rat. Synapse. 23:1996;125-131.
9. Cummings J.L., Frankel M. Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions. Biol. Psychiatry. 20:1985;117-126.
10. De Deurwaerdere P., Bonhomme N., Lucas G., Le Moal M., Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66:1996;210-215.
11. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
12. Descarries L., Audet M.A., Doucet G., Garcia S., Oleskevich S., Seguela P., Soghomonian J.J., Watkins K.C. Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationships. Ann. NY Acad. Sci. 600:1990;81-92.
13. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.S., King P., Pappas N., Brodie J.D., Ashby C.R. Jr. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
14. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
15. Erlander M.G., Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 3:1991;215-226.
16. George M.S. Obsessive-compulsive disorder. Int. Clin. Psychopharmacol. Suppl. 3:1991;57-662.
17. 3H]BIMU-1. Neuropharmacology. 33:1994;1027-1038.
18. Jiang L.H., Ashby C.R. Jr., Kasser R.J., Wang R.Y. The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res. 513:1990;156-160.
19. Kahn R.S., Davidson M. Serotonin, dopamine and their interactions in schizophrenia. Psychopharmacology. 112:1993;S1-S4.
20. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA. 84:1987;881-885.
21. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharm. Exp. Ther. 274:1995;866-876.
22. Laprade N., Soghomonian J.J. MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport. 6:1995;1885-1889.
23. Laprade N., Soghomonian J.J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Mol. Brain Res. 34:1995;65-74.
24. Li M.Y., Yan Q.S., Coffey L.L., Reith M.E.A. Extracellular dopamine, norepinephrine and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66:1996;559-568.
25. Liu Y., Tseng C., Huang N., Yin T., Tung C. Serotonergic serotonin 2 receptor modulation on DOPAC and 5-HIAA levels in rat striatum and nucleus accumbens: microdialysis studies of freely moving rats. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 20:1996;307-322.
26. Mengod G., Pompeiano M., Martinez-Mir M.I., Palacios J.M. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res. 524:1990;139-143.
27. r 67,000) in the basal ganglia of the rat. J. Comp. Neurol. 318:1992;245-254.
28. M.J. Mijnster, A.G.V. Raimundo, K. Koskuba, H. Klop, G.J. Docter, H.J. Groenewegen, P. Voorn, Regional and cellular distribution of serotonin 5-HT2a receptor mRNA in the nucleus accumbens, olfactory tubercle and caudate putamen of the rat, submitted.
29. M.J. Mijnster, A. Schotte, G.J. Docter, P. Voorn, Effects of risperidone and haloperidol on neuropeptide mRNA levels in the caudate putamen and nucleus accumbens of the rat, submitted.
30. Mocchetti I., Giorgi O., Schwartz J.P., Costa E. A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins. Eur. J. Pharmacol. 106:1985;427-430.
31. Morris B.J., Reimer S., Höllt V., Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Brain Res. 464:1988;15-22.
32. Nissbrandt H., Waters N., Hjorth S. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;12-19.
33. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
34. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, London, 1986.
35. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: II. Serotonin-2 receptors. Brain Res. 346:1985;231-249.
36. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
37. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50:1992;1683-1690.
38. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Mol. Brain Res. 23:1994;163-178.
39. Pranzatelli M.R. Evidence for involvement of 5-HT2c and 5-HT1c receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenylaminopropane)-2 (DOI). Neurosci. Lett. 115:1990;74-80.
40. Ruat M., Traiffort E., Arrang J., Tardivel-La Combe J., Diaz J., Leurs R., Schwarz J. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Comm. 193:1993;268-276.
41. Rutter J.J., Auerbach S.B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharm. Exp. Ther. 265:1993;1319-1324.
42. Rutter J.J., Gundlah C., Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171:1994;183-186.
43. Rutter J.J., Gundlah C., Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse. 20:1995;225-233.
44. Sivam S.P. Serotonergic regulation of striatal dynorphin and substance P systems: a study with serotonin uptake inhibitor fluoxetine. Neurosci. Res. Comm. 17:1995;209-215.
45. Smiley P.L., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharm. Exp. Ther. 253:1990;938-943.
46. Soghomonian J.J., Descarries L., Watkins K.C. Serotonin innervation in adult rat neostriatum: II. Ultrastructural features: a radioautographic and immunocytochemical study. Brain Res. 481:1989;67-86.
47. Van Bockstaele E.J., Pickel V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol. 334:1993;603-617.
48. Walker P.D., Capodilupo J.G., Wolf W.A., Carlock L.R. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Res. 732:1996;25-35.
49. Walker P.D., Riley L.A., Hart R.P., Jonakait G.M. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions. Brain Res. 557:1991;31-36.
50. Walker P.D., Riley L.A., Hart R.P., Jonakait G.M. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res. 546:1991;33-39.
51. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.
52. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
53. Yadid G., Pacak K., Kopin I.J., Goldstein D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharm. Exp. Ther. 270:1994;1158-1165.
54. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259:1984;14301-14308.
55. W.S. Young, In situ hybridization histochemistry, in: F.G. Wouterlood, A.N. Van den Pol (Eds.), Methods for the Study of Neuronal Microcircuits and Synaptic Interactions, Handbook of Chemical Neuroanatomy, Vol. 8, Elsevier, Amsterdam, 1990, pp. 481-512.